We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Monitoring Pulmonary Artery Pressure by Implantable Device Responding to Ultrasonic Signal (PAPIRUS III) (PAPIRUSIII)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00893828
Recruitment Status : Completed
First Posted : May 6, 2009
Last Update Posted : February 17, 2017
Information provided by (Responsible Party):
Boston Scientific Corporation

Brief Summary:
The PAPIRUS III study will continue to follow patients initially enrolled in PAPIRUS II. Pressure readings from the investigational device will continue to be collected and will be correlated to physiological changes during activities of daily living and protocol defined tests.

Condition or disease
Heart Failure

Detailed Description:
This is a small clinical trial to determine the feasibility of a device & to test prototype device, where the primary outcome measure relates to feasibility and not to health outcomes.

Study Type : Observational
Actual Enrollment : 18 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Monitoring Pulmonary Artery Pressure by Implanted Device Responding to Ultrasonic Signal
Actual Study Start Date : March 2009
Primary Completion Date : September 2011
Study Completion Date : January 2017

Primary Outcome Measures :
  1. Continue detailed data collection of pressure readings from patients implanted with a RemonCHF device. [ Time Frame: 24 months ]

Biospecimen Retention:   None Retained
Whole Blood

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients previously implanted with a RemonCHF device

Inclusion Criteria:

  • Patient has been enrolled in the PAPIRUS II Study and has a RemonCHF pressure sensor implanted
  • Patient is willing and able to provide informed consent, participate in the Safety Follow-up Program and/or in the required tests associated with the clinical investigation (Core Study Program) at an approved clinical investigational center and at the intervals defined by the Clinical Investigational Plan.

Exclusion Criteria:

  • Patient enrolled in PAPIRUS II but not implanted with a RemonCHF Pressure Sensor
  • Patients who are currently enrolled in another investigational study or registry that would directly interfere with the current study (with the exception of the PAPIRUS II Study). Each instance would be brought to the sponsor to determine eligibility.
  • Age < 18 years
  • Women of childbearing potential who are, or might be, pregnant at the time of the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00893828

University of Cologne
Cologne, Germany
Sponsors and Collaborators
Boston Scientific Corporation
Principal Investigator: Uta C Hoppe, Prof. Dr. University of Cologne

Responsible Party: Boston Scientific Corporation
ClinicalTrials.gov Identifier: NCT00893828     History of Changes
Other Study ID Numbers: Rev. B, 29-Sep-08
First Posted: May 6, 2009    Key Record Dates
Last Update Posted: February 17, 2017
Last Verified: February 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases